Piroxicalm

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Piroxicalm

Quick Facts: Piroxicalm (Piroxicam)

Property Description
Active ingredient Piroxicam
Pharmacological class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Primary Forms Capsules, tablets, gels, injectable solutions
Origin Synthetic (chemically manufactured)
Therapeutic Goal Symptomatic relief of pain, inflammation, and fever

Piroxicalm: Identity and Pharmacological Classification

Piroxicalm is a proprietary pharmaceutical preparation whose single active ingredient is Piroxicam, a synthesized chemical compound. This medicine is formally classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID), specifically belonging to the oxicam derivative class. Piroxicam is clinically recognized for its efficacy in managing pain and inflammation and is a prescription-only medication in many jurisdictions. As an NSAID of the oxicam family, Piroxicam is particularly known for its extended half-life, a property that distinguishes it from more commonly administered, short-acting NSAIDs, providing sustained therapeutic coverage.


Origin, Composition, and Available Forms of Piroxicalm

Piroxicam is a synthetic compound whose precise molecular identity is defined in pharmaceutical databases. Piroxicalm is consistently formulated as a single-active ingredient product. It is available in a comprehensive range of dosage forms, including capsules and tablets for oral administration, as well as gels for topical application. The availability of multiple routes, including parenteral and rectal forms, supports its use in various settings, such as for patients requiring systemic relief or localized treatment.


Primary Therapeutic Function: Pain, Inflammation, and Fever Management

The primary therapeutic function of Piroxicalm is to provide symptomatic relief for pain, inflammation, and fever. The mechanism involves the inhibition of inflammatory signals within the body. This action provides long-lasting relief that is not solely analgesic but comprehensively addresses the discomfort and physical swelling associated with inflammatory processes.

What side effects are possible with Piroxicalm?

Piroxicalm (Piroxicam) is a nonsteroidal anti-inflammatory drug (NSAID) and carries risks associated with this drug class. It should be used at the lowest effective dose for the shortest duration possible to minimize risk.


Serious Warnings and Risks

Like other NSAIDs, Piroxicam may increase the risk of serious cardiovascular (CV) thrombotic events, including heart attack and stroke, which can be fatal. This risk may increase with the duration of use and for people with pre-existing heart disease. It is generally contraindicated for pain after coronary artery bypass graft (CABG) surgery.

Piroxicam also increases the risk of serious gastrointestinal (GI) adverse events, such as bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal and may occur without warning symptoms. The risk is higher for older adults or those with a history of GI disease.

Serious, life-threatening skin reactions, including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), have been reported. Stop taking the medication immediately and seek medical help if you develop a rash, blistering, or peeling skin.


Common Side Effects

Common side effects, primarily affecting the GI system, may include:

System Common Side Effects (Examples)
Gastrointestinal Heartburn, upset stomach, nausea, vomiting, diarrhea, constipation, gas, stomach pain
Nervous System Dizziness, headache, ringing in the ears (tinnitus)
Other Fluid retention (edema), itching, rash

When to Seek Immediate Medical Attention

Seek emergency help if you experience signs of a heart attack (e.g., chest pain, shortness of breath, sudden weakness), stroke (e.g., slurred speech, sudden numbness), GI bleeding (e.g., black or tarry stools, vomiting blood), or a severe allergic reaction (e.g., swelling of the face, throat, or tongue; hives, trouble breathing).

Overdose and Emergency Response

Overdose and When to Seek Help

This section outlines the officially documented manifestations of Piroxicalm (Piroxicam) overdose and the required emergency actions, as established in government regulatory prescribing information.

Documented Overdose Manifestations

An overdose may lead to symptoms involving several body systems. Documented manifestations include gastrointestinal effects (nausea, vomiting, abdominal pain, heartburn, diarrhea) and central nervous system effects (drowsiness, headache, confusion, unsteadiness, or agitation).

Severe outcomes can include serious events like gastrointestinal bleeding, ulceration, and perforation. Life-threatening CNS effects such as convulsions (seizures) or coma are also officially documented.

Required Emergency Actions

Situation Mandated Action (Regulatory Requirement)
Suspected Overdose Call a Poison Control Center or emergency services immediately.
Life-Threatening Symptoms Seek urgent medical attention if the person collapses, has a seizure, cannot be awakened, or has difficulty breathing.

There is no specific antidote documented for Piroxicam overdose. Management is symptomatic and supportive, as defined by regulatory authorities. This may include professional observation, monitoring of vital signs, and procedures such as administering activated charcoal to reduce drug absorption.

Therapeutic Uses of Piroxicalm

What Piroxicalm Treats: Main Uses and Benefits

Piroxicalm is generally applied in situations involving certain distressing symptoms related to inflammatory or irritative states. This medication is commonly used to help with symptoms of Rheumatoid Arthritis (RA), Osteoarthritis (OA), and Ankylosing Spondylitis, as well as acute episodes such as gouty arthritis and primary dysmenorrhea.

Addressing Symptom Clusters

Piroxicalm is relevant for managing symptom clusters that may become intense or disruptive, specifically joint pain, swelling, and functional stiffness. It is applied across domains where additional symptomatic support is needed to address discomfort and restricted movement. The medication supports patients during difficult episodes by easing distress and assists with maintaining functional stability.

Quick Fact: Symptomatic Support for Inflammatory Pain

Symptom Domain Target Clinical Use Patient Benefit
Pain & Inflammation Chronic inflammatory joint diseases (RA, OA) Contributes to improved comfort during symptomatic periods.
Acute Swelling Sudden flare-ups (e.g., Acute Gout) Provides support that helps ease the overall symptom burden.
Functional Discomfort Musculoskeletal injury, Dysmenorrhea Provides supportive relief when symptoms interfere with routine activities.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Piroxicalm (piroxicam) is a nonsteroidal anti-inflammatory drug (NSAID) used to manage the symptoms of conditions like rheumatoid arthritis and osteoarthritis. As with all medications, suitability for use is based on individual health status and medical history.


Contraindications (Who Cannot Use)

Piroxicalm is contraindicated in patients with a known history of hypersensitivity or allergic-type reactions (e.g., asthma, urticaria) to aspirin or other NSAIDs. It must not be used:

  • After coronary artery bypass graft (CABG) surgery.
  • With active or a history of gastrointestinal ulceration, bleeding, or perforation.
  • During the third trimester of pregnancy (starting at 30 weeks' gestation) due to risk of harm to the fetus.
  • With concomitant use of other NSAIDs, including COX-2 selective inhibitors or analgesic doses of aspirin.

Use with Caution (Warnings)

Piroxicalm carries an increased risk of serious cardiovascular thrombotic events (e.g., heart attack, stroke), and this risk may increase with duration of use. Patients with existing cardiovascular disease or risk factors should use it with caution and at the lowest effective dose for the shortest possible duration. Caution is also advised in patients with:

  • Hypertension (high blood pressure) or heart failure.
  • Pre-existing kidney or liver impairment.
  • Bleeding disorders or those taking anticoagulants.

Elderly patients are at greater risk for serious gastrointestinal and renal adverse events and should be closely monitored.

What should I know about interactions with other medicines?

Piroxicalm’s official interaction profile details specific requirements for co-administration with other medicines and products. The regulatory labeling explicitly states that Piroxicalm is contraindicated with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including COX-2 selective agents and analgesic doses of aspirin. Co-administration with anticoagulants is also formally restricted due to a significantly increased risk of bleeding. The use of Piroxicalm is also prohibited in the setting of peri-operative pain related to Coronary Artery Bypass Graft (CABG) surgery.

A key pharmacokinetic interaction involves the metabolic enzyme Cytochrome P450 2C9 ( CYP2C9). Individuals who are CYP2C9 poor metabolizers may experience abnormally high systemic concentrations of Piroxicam, which is a population-specific consideration noted in the labeling. Furthermore, Piroxicalm can officially increase the plasma concentrations of certain co-administered drugs, including Lithium and Digoxin.

Pharmacodynamic interactions can reinforce risk. Combining Piroxicalm with agents such as SSRIs, SNRIs, or oral corticosteroids increases the potential for serious gastrointestinal complications. Co-administration with ACE Inhibitors, ARBs, or diuretics may diminish their therapeutic effect and heighten the risk of renal function deterioration, particularly in elderly or volume-depleted patients. Finally, the consumption of alcohol is officially associated with an increased risk of severe gastrointestinal complications while taking Piroxicalm.

Mechanism of Action

How Piroxicalm Works

Piroxicalm's mechanism of action is rooted in the direct, reversible inhibition of the cyclooxygenase (COX) enzyme system, which is the foundational step for modulating the key physiological pathways associated with nociception, inflammatory responses, and thermoregulation.


Non-Selective Inhibition of COX-1 and COX-2 Enzymes

The core action of Piroxicalm (Piroxicam) involves the binding and inhibition of two enzymes, Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2). These enzymes are necessary for the initial conversion of arachidonic acid into potent signaling molecules called prostaglandins. This molecular interaction blocks the production of these mediators.


Modulation of Nociceptive and Inflammatory Pathways

By restricting prostaglandin synthesis, the drug modulates both peripheral nociceptive signaling and the inflammatory response. The reduced levels of prostaglandins diminish the sensitization of pain-sensing nerve fibers, which alters the input to the transmission of nociceptive signals. Simultaneously, the drug limits the impact of these pro-inflammatory chemicals on local blood vessels, which results in the modulation of vascular permeability and fluid accumulation associated with the inflammatory state.


Central Adjustment of Thermoregulation

The central action of this mechanism involves the hypothalamus. Piroxicalm reduces prostaglandin E2 ( PGE2) production within this brain center. This central suppression reverses the pathological setting of the body’s thermostat, thereby adjusting the central set-point and contributing to the physiological process of core temperature regulation.

Dosage and Administration Information

How to Use Piroxicalm

This section outlines the general principles of Piroxicalm (Piroxicam) administration, including routes, dosage schedules, and official constraints.


Administration Routes and Dosing Patterns

The primary method of administration for Piroxicalm is the oral route, utilizing capsules or tablets. The intramuscular (IM) injection is an official, approved route but is strictly limited for initial use in acute conditions when oral administration is not feasible.

For chronic inflammatory conditions, the typical maintenance dose is 20 mg administered once daily, although the dose may be divided into 10 mg twice a day. The maximum recommended daily dose for long-term use is 20 mg. For acute conditions, such as gouty arthritis, a higher initial dose, such as 40 mg daily, is used for a short, defined period of four to six days before therapy is discontinued or adjusted.


Administration Conditions and Procedural Rules

Feature Official Labeled Instruction
Timing in relation to meals Oral forms should be taken with or immediately after food to help mitigate gastrointestinal discomfort.
Capsule Administration Capsules must be swallowed whole and should not be crushed or chewed.
IM Use Duration Use of the injectable form is typically restricted to an initial course of 2 to 3 days, followed by a rapid transition to the oral route for continuation of therapy.
Dose Limit The total daily dosage of Piroxicalm from all administered forms must not exceed the maximum daily dose.

Population-Specific Use

Older adults should receive the lowest effective dose for the shortest possible duration. Furthermore, dose reduction is a necessary consideration for individuals with known or suspected impaired renal or hepatic function due to the risk of altered drug elimination. For chronic use, the need for continued treatment must be formally re-evaluated within 14 days of therapy initiation.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research has explored the compound's characteristics. Studies have been conducted to examine outcomes related to pain and mobility in participants with severe osteoarthritis and rheumatoid arthritis. The research evaluated the compound's profile across various phases of clinical investigation.


Key Clinical Trials

Key clinical trials have examined the compound's effects, reporting on outcomes related to the time course of reported changes and on changes in joint stiffness. These studies were generally placebo-controlled and involved adult participants diagnosed with inflammatory joint conditions.

Combination vs. Monotherapy

The combination of the two ingredients was included as a comparator against single-agent therapy in some research. These trials primarily focused on quantifying differences in scores on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and patient-reported pain scales. The reports quantified differences in outcomes between the combined approach and its individual components.

Pharmacokinetic Studies

Studies examining pharmacokinetics investigated how administration under various conditions impacted absorption. Research has also examined findings related to various administration timing protocols. Further research has evaluated newer formulations and their reported outcomes.


Reported Side Effects

Initial research has documented the reported side effects, noting the type and frequency of events observed across study populations. Like other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), its use has been associated with risks, particularly serious gastrointestinal (GI) and cardiovascular adverse events.

Special Populations

Studies have investigated the compound's effects across different patient demographics. Research has reported specific outcomes for elderly participants. Research has also examined the compound's effects on participants identified as having renal impairment. Long-term studies have reported on the consistency of findings over time, monitoring participants for up to five years. Research has investigated this compound, examining changes in markers of inflammation, such as C-Reactive Protein (CRP).

Key Studies & References

  1. American College of Rheumatology (ACR) Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee

Frequently Asked Questions (FAQ)

Common questions about Piroxicalm (FAQ)


Q: How quickly does Piroxicalm start working for pain?

A: Piroxicam, the active ingredient, has an extended half-life. Because of this, it may take several days for the drug to build up to steady-state levels in the bloodstream. While some initial therapeutic effects may be noticed earlier, the full therapeutic response is typically assessed after about two weeks of consistent use, according to regulatory information.

Q: How long does the effect of Piroxicalm last?

A: Official pharmacological data indicates that Piroxicam has an extended plasma half-life of approximately 50 hours. This long duration of action is the reason why the medication is often prescribed to be taken once daily.

Q: Is Piroxicalm generally considered safe to use long-term?

A: Regulatory documents recommend against prolonged use. To minimize the risk of serious cardiovascular and gastrointestinal adverse events, official guidance states that the drug should be used at the lowest effective dose for the shortest possible duration. The risks associated with this medication are known to increase with the duration of use.

Q: What happens if I miss a dose of Piroxicalm?

A: If a dose is missed, official instructions suggest taking it as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed one should be skipped entirely, and the regular dosing schedule should be continued. Official drug information clearly advises against taking a double dose to compensate for a missed dose.

Q: Can you buy Piroxicalm over the counter?

A: Piroxicam, the active ingredient in Piroxicalm, is formally classified as a prescription-only medication in the United States and in many other countries. It is not available for purchase without a valid prescription from a licensed healthcare provider.

Q: Does Piroxicalm interact with blood pressure medication?

A: Yes, Piroxicalm can interact with certain blood pressure treatments. According to the label, it may lessen the effectiveness of medications like ACE inhibitors, ARBs, and diuretics. The combination can also heighten the risk of developing new or worsening pre-existing high blood pressure.

Q: Are there any vitamins or supplements that interact with Piroxicalm?

A: Regulatory labels contain warnings that a healthcare provider should be informed about all substances being taken, including prescription and over-the-counter medicines, vitamins, minerals, and herbal products. Although specific vitamins are not always listed, the general warning includes supplements because they may have potential interactions with Piroxicam.

Q: Does Piroxicalm affect driving or operating machinery?

A: Piroxicalm can cause central nervous system side effects, such as dizziness, headaches, and drowsiness. Due to the potential for these effects, caution is warranted when driving or operating machinery.

Q: Can pregnant women or those planning pregnancy use Piroxicalm?

A: Piroxicam is strictly contraindicated starting at 20 weeks of pregnancy or later due to the risk of harm to the developing fetus, including potential kidney problems. In the first and second trimesters, the drug is only used if a medical provider determines that the potential benefit justifies the potential risks.

Q: Can children ever take Piroxicalm?

A: Official regulatory information indicates that the safety and effectiveness of Piroxicam have not been established in the pediatric population. Therefore, the medication is not approved for use in children who are younger than 18 years of age.

Q: What kind of research supports the use of Piroxicalm?

A: Regulatory submissions for the drug include data from clinical trials. These studies support the use of Piroxicalm for relieving the signs and symptoms associated with rheumatoid arthritis and osteoarthritis in adults.

Q: Can Piroxicalm be used for headaches or migraines?

A: Official regulatory indications only approve Piroxicalm for the symptomatic relief of rheumatoid arthritis and osteoarthritis. Its use for headaches or migraines is not among the formal, FDA-approved indications.

Q: What should I do if I think I'm having an allergic reaction to Piroxicalm?

A: If signs of a serious allergic reaction occur, such as hives, trouble breathing, swelling of the face or throat, or blistering/peeling skin, the medication should be stopped immediately. Emergency medical help should be sought right away.

Q: Does Piroxicalm affect kidney function?

A: Yes. Regulatory warnings state that Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including Piroxicam, can potentially cause new or worsening kidney dysfunction. Individuals with pre-existing kidney impairment are advised to use the medication with caution.

Q: Can Piroxicalm cause sleeplessness (insomnia)?

A: Yes, regulatory documents list sleeplessness, or insomnia, as one of the adverse reactions that have been reported by patients using Piroxicam.

Q: What is the maximum number of days I can take Piroxicalm?

A: Regulatory documents do not specify a single, fixed maximum duration for all uses. Instead, they emphasize that due to the increased risk of side effects over time, the medicine should always be used for the shortest duration necessary to achieve relief, regardless of the condition being treated.

Q: Is there a generic version of Piroxicalm available?

A: Yes, Piroxicam is the active ingredient and is available from various pharmaceutical manufacturers in a generic form. This is in addition to the availability of the brand-name products.

Q: Are there any dietary restrictions when taking Piroxicalm?

A: There are generally no special dietary restrictions required while taking this medication. However, the oral form should be taken with or immediately after food to help reduce the potential for stomach upset or gastrointestinal discomfort.

Q: What are the signs of an overdose of Piroxicalm?

A: Symptoms of a severe overdose may include severe stomach pain, bloody or tarry stools, unusual drowsiness, agitation, or confusion. In the event of a suspected overdose, immediate emergency medical assistance is required.

Q: What is the chemical structure of the Piroxicalm molecule?

A: Piroxicam, the active ingredient, is chemically classified as an oxicam derivative. This molecular structure is what places it in the Non-Steroidal Anti-Inflammatory Drug (NSAID) class and is known to contribute to its long half-life.

Q: Does Piroxicalm have any effect on mood or anxiety?

A: Yes. Official adverse event reporting includes nervous system reactions such as anxiety, confusion, and depression among the reported side effects associated with the use of Piroxicam.

Q: Are there any long-term risks associated with Piroxicalm use?

A: Yes, official warnings highlight serious risks with extended use. Long-term use increases the risk of life-threatening cardiovascular thrombotic events, such as heart attack or stroke, and serious gastrointestinal complications, including ulceration, bleeding, or perforation.

Q: What is the therapeutic window for Piroxicalm?

A: The official label does not provide a fixed 'therapeutic window.' However, regulatory information notes that individuals who are poor metabolizers of the CYP2C9 enzyme may experience abnormally high drug levels in their system. This factor requires that a healthcare provider may need to consider a dose reduction for this specific patient population.

Q: Does Piroxicalm have any known interactions with herbal teas?

A: Official prescribing information requires patients to inform their healthcare provider about all herbal products they are currently using. Although specific herbal teas are not named, they fall under the general warning for herbal products that may interact with Piroxicam.

How should Piroxicalm be stored and disposed of?

How to Store and Dispose of Piroxicalm?

Official regulatory guidelines define specific conditions for storing and discarding Piroxicalm (Piroxicam) to maintain its stability and ensure safety.

Storage Requirements

Condition Requirement (Official Label)
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). Do not freeze or store above 30 C.
Environment Keep away from excessive moisture and heat, meaning storage in the bathroom is prohibited. Protect from direct light.
Packaging Keep the medication in the original container, ensuring the container is tightly closed.
Child Safety Mandatory to keep Piroxicalm out of the sight and reach of children. Lock safety caps immediately after use.

Disposal Protocol

Unused or expired Piroxicalm must be disposed of according to official guidance. The preferred method is returning the product to a drug take-back program. If a take-back program is unavailable, the product should be mixed with an undesirable substance (e.g., dirt, used coffee grounds) and sealed before placing it in the household trash. Piroxicalm must not be flushed down the toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Piroxicalm found in:

A-Z Index: